Therapeutic potential of panax ginseng-derived nanovesicles in osteoporosis through enhanced osteoblast
Journal of Ginseng Research · 2026-05 · 50 (3) · 101016
DOI: 10.1016/j.jgr.2026.101016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ginseng Research, 2026-05. Verfasst von Sang-Hoon Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food and Nutrition, Gyeongkuk National University, Andong, 36729, Republic of Korea. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Korean Society of Ginseng, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Background
Osteoporosis is a skeletal disorder caused by an imbalance between bone resorption and formation, which leads to reduced bone density and increased fracture risk. Plant-derived nanovesicles have emerged as safe, biocompatible biomaterials with therapeutic potential for bone regeneration.
Methods
In this work, the biological effects of Panax ginseng-derived nanovesicles (PNVs) were evaluated with a focus on osteoblast differentiation, bone formation, and mineralization. PNVs were successfully isolated, characterized, and tested for their osteogenic capacity using MC3T3-E1 cells, mouse primary osteoblasts, and osteoclasts.
Results
Treatment with PNVs (0-10 μg/mL) for 3 or 7 days markedly promoted osteoblastic maturation and matrix mineral deposition, as confirmed by Alizarin-red and Von Kossa staining. In addition, PNVs exposure upregulated key osteogenic genes, including Runx2, ALP, and OPN, while activating major signaling cascades such as BMP2/4 and phosphorylated p38, implying their involvement in osteogenic regulation. Moreover, in an ovariectomized (OVX) mouse model, oral administration of PNVs improved bone microarchitecture by stimulating osteoblast-driven bone regeneration and attenuating osteoclast-mediated bone degradation.
Conclusions
Collectively, our findings indicate that PNVs promote osteoblast differentiation and bone matrix formation, thereby enhancing mineralization and demonstrating their potential as a natural nanotherapeutic approach for osteoporosis prevention and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Food and Nutrition, Gyeongkuk National University, Andong, 36729, Republic of Korea.
- Korea Zoonosis Research Institute, Jeonbuk National University, Iksan, 54531, Republic of Korea.
- Research Institute of Women's Health, Sookmyung Women's University, Seoul, 04312, Republic of Korea.
- School of Integrative Engineering, Chung-Ang University, Seoul, 06974, Republic of Korea.
- College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Korean Society of Ginseng
- Ministry of Science and ICT, South Korea
Zitieren
APA
Lee, S. H., Kwon, J. H., Kim, H. W., Mun, S. H., Yang, Y., Kim, J., Seo, K. W., Kim, D. K., & Cho, Y. E. (2026). Therapeutic potential of panax ginseng-derived nanovesicles in osteoporosis through enhanced osteoblast. Journal of Ginseng Research, 50(3), 101016. https://doi.org/10.1016/j.jgr.2026.101016
Vancouver
Lee SH, Kwon JH, Kim HW, Mun SH, Yang Y, Kim J, et al. Therapeutic potential of panax ginseng-derived nanovesicles in osteoporosis through enhanced osteoblast. Journal of Ginseng Research. 2026;50(3):101016. doi:10.1016/j.jgr.2026.101016
BibTeX
@article{Lee2026,
author = {Lee, Sang-Hoon and Kwon, Jae-Hee and Kim, Hyun-Woo and Mun, Se Hwan and Yang, Young and Kim, Jihoon and Seo, Kwang-Won and Kim, Do-Kyun and Cho, Young-Eun},
title = {Therapeutic potential of panax ginseng-derived nanovesicles in osteoporosis through enhanced osteoblast},
journal = {Journal of Ginseng Research},
year = {2026},
volume = {50},
number = {3},
pages = {101016},
doi = {10.1016/j.jgr.2026.101016}
}
EUVIMED